院前卒中流程优化对急性缺血性卒中治疗延迟与临床结局的影响:系统评价与荟萃分析
该系统评价与荟萃分析纳入27篇文献(26篇进入荟萃分析),评估院前卒中流程优化(PSWO)对急性缺血性卒中治疗时间、再灌注率及临床结局的影响。PSWO分为改善静脉溶栓(IVT)分诊、大血管闭塞(LVO)绕行和移动卒中单元(MSU)三类。改善IVT分诊显著提高IVT率(RR=1.80,95%CI 1.18-2.75),MSU未显著提高(RR=1.22,95%CI 0.98-1.52);三类PSWO均显著缩短door-to-needle时间,MSU还显著缩短call-to-needle、onset-to-needle及EVT的door-to-perfusion和call-to-perfusion时间。但PSWO未显著改善良好功能结局(RR=1.04,95%CI 0.97-1.12)或90天死亡率(RR=1.00,95%CI 0.76-1.31)。
要点
- 改善IVT分诊显著提高IVT率(RR=1.80,95%CI 1.18-2.75),MSU未显著提高(RR=1.22,95%CI 0.98-1.52)。
- 改善IVT分诊(SMD=-0.82)、LVO绕行(SMD=-0.80)、MSU(SMD=-0.87)均显著缩短door-to-needle时间。
- MSU显著缩短call-to-needle(SMD=-1.41)和onset-to-needle(SMD=-1.15)时间。
- MSU显著缩短EVT的door-to-perfusion(SMD=-0.72)和call-to-perfusion(SMD=-0.73)时间。
- PSWO未显著改善90天良好功能结局(RR=1.04,95%CI 0.97-1.12)或死亡率(RR=1.00,95%CI 0.76-1.31)。
适用人群与场景
- 急性缺血性卒中患者,涉及院前急救与卒中网络流程。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 改善IVT分诊:可显著提高IVT率并缩短door-to-needle时间。
- LVO绕行:可显著缩短door-to-needle时间。
- 移动卒中单元(MSU):可显著缩短door-to-needle、call-to-needle、onset-to-needle时间,以及EVT的door-to-perfusion和call-to-perfusion时间。
- 原文未提及具体药物剂量、给药途径、频次或目标值。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:系统评价与荟萃分析,纳入27篇文献(26篇进入荟萃分析)。
- 改善IVT分诊显著提高IVT率(RR=1.80,95%CI 1.18-2.75);MSU未显著提高(RR=1.22,95%CI 0.98-1.52)。
- 改善IVT分诊(SMD=-0.82,95%CI -1.32至-0.32)、LVO绕行(SMD=-0.80,95%CI -1.13至-0.47)、MSU(SMD=-0.87,95%CI -1.57至-0.17)均显著缩短door-to-needle时间。
- MSU显著缩短call-to-needle(SMD=-1.41,95%CI -1.94至-0.88)和onset-to-needle(SMD=-1.15,95%CI -1.74至-0.56)时间。
- MSU显著缩短EVT的door-to-perfusion(SMD=-0.72,95%CI -1.32至-0.12)和call-to-perfusion(SMD=-0.73,95%CI -1.08至-0.38)时间。
- PSWO未显著改善良好功能结局(RR=1.04,95%CI 0.97-1.12)或90天死亡率(RR=1.00,95%CI 0.76-1.31)。
证据类型、等级与局限
- 证据类型:系统评价与荟萃分析。
- 遵循PRISMA指南,检索PubMed、Cochrane、Medline、Embase自2005年以来的文献。
- 局限:原文指出可用数据有限,功能结局和死亡率未显著改善,需进一步研究。
对床旁实践的改变
- 院前卒中流程优化可改善时间指标和IVT率,但现有证据未显示功能结局或死亡率获益,实施时需结合本地卒中网络情况。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The prehospital phase is critical in ensuring that stroke treatment is delivered quickly and is a major source of time delay. This study sought to identify and examine prehospital stroke workflow optimizations (PSWOs) and their impact on improving health systems, reperfusion rates, treatment delays, and clinical outcomes.
METHODS: The authors conducted a systematic literature review and meta-analysis by extracting data from several research databases (PubMed, Cochrane, Medline, and Embase) published since 2005. We used appropriate key search terms to identify clinical studies concerning prehospital workflow optimization, following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
RESULTS: The authors identified 27 articles that looked at the impact of prehospital workflow optimizations on time and treatment parameters; 26 were included in the meta-analysis. The PSWO were subgrouped into three categories: improved intravenous thrombolysis (IVT) triage, large-vessel occlusion (LVO) bypass, and mobile stroke unit (MSU). The salient findings are as follows: improved IVT triage led to significantly improved rates of IVT (relative risk [RR] = 1.80, 95% confidence interval [CI] = 1.18 to 2.75); however, MSU did not (RR = 1.22, 95% CI = 0.98 to 1.52). Improved IVT triage (standard mean difference [SMD] = -0.82, 95% CI = -1.32 to -0.32), LVO bypass (SMD = -0.80, 95% CI = -1.13 to -0.47), and MSU (SMD = -0.87, 95% CI = -1.57 to -0.17) were found to significantly reduce door-to-needle time for IVT. MSU was found to significantly reduce call-to-needle (SMD = -1.41, 95% CI = -1.94 to -0.88) and onset-to-needle (SMD = -1.15, 95% CI = -1.74 to -0.56) times for IVT. MSU additionally demonstrated significant reduction in door-to-perfusion (SMD = -0.72, 95% CI = -1.32 to -0.12) as well as call-to-perfusion (SMD = -0.73, 95% CI = -1.08 to -0.38) times for EVT. Finally, PSWO did not demonstrate significant improvements in rates of good functional outcome (RR = 1.04, 95% CI = 0.97 to 1.12) or mortality at 90 days (RR = 1.00, 95% CI = 0.76 to 1.31).
CONCLUSIONS: This systematic review and meta-analysis found that PSWO significantly improves several time metrics related to stroke treatment leading to improvement in IVT reperfusion rates. Thus, the implementation of these measures in stroke networks is a promising avenue to improve an often-neglected aspect of the stroke response. However, the limited available data suggest functional outcomes and mortality are not significantly improved by PSWO; hence, further studies and improvement strategies vis-à-vis PSWOs are warranted.
参考来源
- Chowdhury SZ, Baskar PS, Bhaskar S, et al. Effect of prehospital workflow optimization on treatment delays and clinical outcomes in acute ischemic stroke: A systematic review and meta-analysis. Acad Emerg Med. 2021. PMID: 33387368. doi:10.1111/acem.14204
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。